These tumor suppressive effects of miR-34a are mediated by changes in a number of target mRNAs including MYCN, CDK4, cyclin D1, SIRT1 and Bcl-2 [18], [51], [52], [53]. The gene discussed is SIRT1; the disease is neoplasm.